Evidence map›Paper›PMID 24706882›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Biologically-active laminin-111 fragment that modulates the epithelial-to-mesenchymal transition in embryonic stem cells.

Christine-Maria Horejs, Andrea Serio, Alan Purvis, Adam J Gormley, Sergio Bertazzo, Anna Poliniewicz, Alex J Wang, Peter DiMaggio, Erhard Hohenester, Molly M Stevens

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Laminin N-terminus α31 expression during development is lethal and causes widespread tissue-specific defects in a transgenic mouse model.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Christine-Maria HorejsDepartments of Materials, Bioengineering, Life Sciences, and Chemical Engineering, and Institute for Biomedical Engineering, Imperial College London, London SW7 2AZ, United Kingdom.
Andrea Serio
Alan Purvis
Adam J Gormley
Sergio Bertazzo
Anna Poliniewicz
Alex J Wang
Peter DiMaggio
Erhard Hohenester
Molly M Stevens
Bioengineering Center · RUImperial College London · GBInstitute of Chemical Engineering · BG

Funding

Medical Research Council MR/K026682/1Wellcome Trust 098411Wellcome Trust 098411/Z/12/ZWellcome Trust 101748
6 · The paper itself

Abstract

The dynamic interplay between the extracellular matrix and embryonic stem cells (ESCs) constitutes one of the key steps in understanding stem cell differentiation in vitro. Here we report a biologically-active laminin-111 fragment generated by matrix metalloproteinase 2 (MMP2) processing, which is highly up-regulated during differentiation. We show that the β1-chain-derived fragment interacts via α3β1-integrins, thereby triggering the down-regulation of MMP2 in mouse and human ESCs. Additionally, the expression of MMP9 and E-cadherin is up-regulated in mouse ESCs--key players in the epithelial-to-mesenchymal transition. We also demonstrate that the fragment acts through the α3β1-integrin/extracellular matrix metalloproteinase inducer complex. This study reveals a previously unidentified role of laminin-111 in early stem cell differentiation that goes far beyond basement membrane assembly and a mechanism by which an MMP2-cleaved laminin fragment regulates the expression of E-cadherin, MMP2, and MMP9.

Indexed as

Epithelial-Mesenchymal TransitionAnimalsBasiginBinding SitesCadherinsCell AdhesionEmbryonic Stem CellsGene Expression RegulationHumansIntegrin alpha3beta1LamininMatrix Metalloproteinase 2Matrix Metalloproteinase 9MicePeptide FragmentsProtein BindingBasiginBsg protein, mouseCadherinsIntegrin alpha3beta1LamininMatrix Metalloproteinase 2Matrix Metalloproteinase 9Peptide FragmentsTissue Inhibitor of Metalloproteinase-1Tissue Inhibitor of Metalloproteinase-2

Identifiers

PMID24706882
PMCPMC4000797
OpenAlexW2141404357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.